Solvay Reports Preliminary Q3 2026 Underlying EBITDA of EUR 173 Million

• Solvay reported preliminary Q3 2026 underlying EBITDA of €173 million and underlying net sales of €1.03 billion.
• The Middle East conflict reduced underlying EBITDA by about €25 million, primarily due to the prolonged shutdown of the Jubail peroxides plant.
• Free cash flow to shareholders from continuing operations totaled €54 million.
• Updated 2026 guidance puts underlying EBITDA at €720 million–€740 million, excluding potential Sadara income or compensation for the remainder of the year.
• On the same basis, projected free cash flow to shareholders from continuing operations ranges from €120 million to €150 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solvay SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610191200OMX_____CNEWS_FR_GNW1001278744_fr) on October 19, 2026, and is solely responsible for the information contained therein.